| Darrel P. Cohen |
Darrel P. Cohen is Chief Medical Officer for Athenex, Inc.
He received a doctorate from Boston University School of Medicine. |
| Timothy Cook |
Presently, Timothy Cook occupies the position of Chief Operating Officer & Vice President at Lilly Oncology. He is also Chief Business & Commercial Officer at Athenex, Inc. |
| Darrel P. Cohen |
Currently, Darrel P. Cohen holds the position of Chief Medical Officer of Athenex, Inc. and Chief Medical Officer for Biosight Therapeutics, Inc.
In the past Dr. Cohen held the position of Vice President-Late Phase Clinical Development at Pfizer Inc. and Associate Director-Oncology Clinical Development at Pharmacia Corp. (a subsidiary of Pfizer Inc.) and Head-Clinical Development at EUSA Pharma, Inc.
Darrel P. Cohen received a doctorate from Boston University School of Medicine. |
| Michael Smolinski |
Currently, Michael Smolinski is Chief Scientific Officer for Athenex, Inc.
In the past Mr. Smolinski was Chief Technology Officer for Homecare Homebase LLC.
Mr. Smolinski received a doctorate from State University of New York at Buffalo. |
| Nick Campbell |
Nick Campbell founded Meru LLC. Currently, Mr. Campbell is Managing Partner at this company. He is also Chief Restructuring Officer at Athenex, Inc. |
| Joe Annoni |
Joe Annoni is Chief Financial Officer of Athenex, Inc.
In his past career Mr. Annoni held the position of Principal at MCI Telecommunications Corp., Managing Director at GFW Partners, Principal at PricewaterhouseCoopers LLP and Research Analyst at ROTH Capital Partners LLC.
Joe Annoni received an MBA from Carnegie Mellon University and an undergraduate degree from the University of Virginia. |
| Steven Adams |
Steven Adams is Chief Accounting Officer & Controller for Athenex, Inc. He is also Vice President-Professional Services at Curl, Inc.
He received an undergraduate degree from The University of Liverpool and a doctorate from the University of London. |
| Yiu Nam Lau |
Yiu Nam Lau is a businessperson who has been at the head of 6 different companies. Presently, Dr. Lau is Chairman & Chief Executive Officer of Athenex, Inc., Chairman of SinoPhyto Solutions LLC, Executive Chairman of XenoBiotic Laboratories, Inc. and Chairman for XBL-China, Inc. Dr. Lau is also Member of The Royal College of Physicians and Managing Partner at Newport Healthcare Advisors LLC and on the board of 8 other companies.
Yiu Nam Lau previously occupied the position of Chairman for Sun Ten Labs Liquidation Co., Chairman & Chief Executive Officer for Ribapharm, Inc., Senior Vice President-Research & Development at Bausch Health Americas, Inc., Senior Director-Antiviral Therapy Research at Schering-Plough Corp. and Managing Director at ROTH Capital Partners LLC.
Dr. Lau received a doctorate from the University of Hong Kong and a doctorate from the University of Hong Kong. |
| William Zuo |
Currently, William Zuo occupies the position of Chairman & President-Polymed Therapeutics at Chongqing Taihao Pharmaceutical Co., Ltd. Dr. Zuo is also President-China Operations at Athenex, Inc.
He previously held the position of Chairman & Chief Executive Officer at InovaChem, Inc. and Chief Executive Officer at Fibrocell Science, Inc.
William Zuo received a doctorate and a graduate degree from Rice University. |
| Daniel Lang |
Founder of Sapient Medical Group, Pllc, Daniel Lang is President-Athenex Cell Therapy at Athenex, Inc.
In his past career Dr. Lang held the position of Chief Financial Officer at Sapient Medical Group, Pllc, Chief Medical Resident at The Mount Sinai Hospital, Senior Associate at Brilleon Capital Us, Inc., Chief Investment Officer of Victory Capital Management, Inc. (Investment Management), Principal at Farallon Capital Management LLC and Analyst at RS Investment Management Co. LLC.
Dr. Lang received an undergraduate degree from Cornell University and a doctorate from Weill Cornell Medical College. |
| Stephanie Davis |
Stephanie Davis is on the board of Athenex, Inc. and The Buckley School. Ms. Davis previously was Senior Client Partner at Korn Ferry, Member of Spencer Stuart, Inc. and Associate of Prudential Investment Corp.
Ms. Davis received an MBA from Harvard Business School and an undergraduate degree from Princeton University. |
| Robert Jay Spiegel |
Robert Jay Spiegel founded Spiegel Consultants, LLC. Presently, Dr. Spiegel holds the position of President at Spiegel Consultants, LLC, Advisor at Warburg Pincus & Company US LLC and Venture Advisor at Israel Biotech Fund. Dr. Spiegel is also Associate Professor at Weill Cornell Medical College and on the board of 6 other companies.
In the past he held the position of Chairman of NexImmune, Inc., Chief Medical Officer of PTC Therapeutics, Inc., Chief Medical Officer & Senior Vice President of Schering-Plough Research Institute, Senior Vice President at Worldwide Clinical Research, Inc. and Director-Developmental Therapeutics at New York University Medical Center.
He received an undergraduate degree from Yale University and a doctorate from the University of Pennsylvania. |
| Jordan Scott Kanfer |
Jordan Scott Kanfer is on the board of Athenex, Inc. and Member of American College of Healthcare Executives.
In the past he was Principal at Hilltop Park Associates LLC, Managing Director at Opti Capital Management LP, Managing Partner at JANA Partners LLC, Portfolio Manager at Arrowgrass Capital Partners (US) LP, Portfolio Manager at RBC Alternative Asset Management, Inc. and Analyst at Goldman Sachs & Co. LLC.
Jordan Scott Kanfer received a graduate degree from the University of Massachusetts and an undergraduate degree from Yeshiva University. |
| John Moore Vierling |
John Moore Vierling is on the board of Athenex, Inc. and National Institute of Diabetes & Digestive & Kidney Diseases and Member of National Institutes of Health and Chief Hepatology & Director-Baylor Liver Health at Baylor College of Medicine.
In his past career he was Chairman at Arbios Systems, Inc., Chairman-Data Safety at Fractyl Health, Inc., Secretary & Treasurer at Digestive Disease Week, Chairman at American Liver Foundation, President of American Association for The Study of Liver Diseases, Hepatology Director at Cedars-Sinai Medical Center and Medical Director-Liver Transplantation at the University of Colorado Health Sciences Center.
John Moore Vierling received an undergraduate degree from Stanford University and a doctorate from Stanford University School of Medicine. |
| Jinn Wu |
Founder of XenoBiotic Laboratories, Inc., Jinn Wu occupies the position of Chairman at AiViva BioPharma, Inc., Chairman at AiViva Holding Ltd. and President & Chief Executive Officer of XenoBiotic Laboratories, Inc. Dr. Wu is also on the board of Athenex, Inc. and Member of American Chemical Society, Member of American Association of Pharmaceutical Scientists, Member of International Society for the Study of Xenobiotics and Member of American Society of Pharmacognosy.
In the past he held the position of Research Scientist at FMC Corp., Chief Scientific Officer & Senior Vice President at Wuxi Apptec, Inc. and Member-College of Pharmacy at The Ohio State University.
He received a doctorate from The Ohio State University. |
| Kwan Hung Tsang |
Currently, Kwan Hung Tsang is Chief Financial Officer for Maxinovel Pharmaceutical, Inc. Mr. Tsang is also on the board of Athenex, Inc., Pharmaron Beijing Co., Ltd. and Puritek Canada, Inc. and Member of Canadian Institute of Chartered Accountants, Member of Hong Kong Institute of Certified Public Accountants, Member of Chartered Professional Accountants of Canada and Partner at Hongsen Investment Management Ltd.
Mr. Tsang previously held the position of Chief Financial Officer of WuXi AppTec Co., Ltd., Chief Financial & Accounting Officer at ATA Creativity Global, Chief Financial Officer for Chongqing Jinshan Science & Technology (Group) Co. Ltd., Chief Financial Officer-China at Guoan International Ltd. and Chief Financial Officer-China at PCCW Ltd.
Kwan Hung Tsang received an undergraduate degree and an MBA from McMaster University. |
